The INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts brand, founded in 2006 (France), from 2757 sister brands and 17478 competing brands. The INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts brand is owned by SANOFI, a company listed in Paris. Its International Securities Identification Number (ISIN) is FR0000120578. INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts is part of the Drug Manufacturers activity sector.

INVOLVE IrbesartaN in the eValuation of the OutLook of high risk cardioVascular patiEnts is a brand of SANOFI (SAN) Other brands

Buy SANOFI share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Other brands
SANOFI